Correlation Between RenovoRx and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Cullinan Oncology LLC, you can compare the effects of market volatilities on RenovoRx and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Cullinan Oncology.
Diversification Opportunities for RenovoRx and Cullinan Oncology
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between RenovoRx and Cullinan is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of RenovoRx i.e., RenovoRx and Cullinan Oncology go up and down completely randomly.
Pair Corralation between RenovoRx and Cullinan Oncology
Given the investment horizon of 90 days RenovoRx is expected to generate 2.42 times less return on investment than Cullinan Oncology. In addition to that, RenovoRx is 1.73 times more volatile than Cullinan Oncology LLC. It trades about 0.01 of its total potential returns per unit of risk. Cullinan Oncology LLC is currently generating about 0.04 per unit of volatility. If you would invest 951.00 in Cullinan Oncology LLC on August 29, 2024 and sell it today you would earn a total of 326.00 from holding Cullinan Oncology LLC or generate 34.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
RenovoRx vs. Cullinan Oncology LLC
Performance |
| Timeline |
| RenovoRx |
| Cullinan Oncology LLC |
RenovoRx and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Cullinan Oncology
The main advantage of trading using opposite RenovoRx and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| RenovoRx vs. Eliem Therapeutics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals | RenovoRx vs. Seres Therapeutics |
| Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. Scpharmaceuticals | Cullinan Oncology vs. Milestone Pharmaceuticals | Cullinan Oncology vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |